Acquisition / mergerNotableFiled on BSE ·

J.B. Chemicals shareholders pass resolution approving Torrent Pharma amalgamation scheme

J B Chemicals & Pharmaceuticals · Pharmaceuticals & Biotechnology

Arthneeti Research DeskPublished 1 min read

Key highlights

  • Scheme of Amalgamation with Torrent Pharmaceuticals Limited passed at the NCLT-convened equity shareholders' meeting held on April 28, 2026.
  • Of 73,425 equity shareholders on the April 21, 2026 cut-off date, 411 voted, polling 131981851 votes via remote e-voting and e-voting during the meeting.
  • Public shareholders cast 52031121 valid votes in favour and 2185 against, meeting the public-vote test under the SEBI Master Circular.

Why it's rated notable: The filing states no value for the scheme, so the level is medium, and the shareholder approval is a step in a scheme that remains subject to further approval, so binding is false.

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from J B Chemicals & Pharmaceuticals

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.